There were 1,679 press releases posted in the last 24 hours and 414,173 in the last 365 days.

Head and Neck Cancer 22 Times More Likely in Patients with Some Types of HPV; the CBCD Reviews a Study

A study looked at rates of head and neck cancer among patients who were found to have HPV-16 infections of the oral cavity. (1)

An emerging body of research shows that an oral-cavity HPV infection can result from sexual activity.
— Dr. Firger
ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, January 28, 2016 /EINPresswire.com/ --

“Infected with the human papillomavirus (HPV)? The CBCD recommends taking Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

Oral infection with certain strains of the human papillomavirus (HPV) can lead to cancer. A study found that “patients with certain types of human papillomavirus (HPV) oral infection are 22 times more likely to develop head and neck cancer later in life.” (1) Dr. Agallieu said that the study is unique “because it shows for the first time that HPV-16 detected in the oral cavity precedes the development of oropharyngeal cancer.” (1) It is important to note that “an emerging body of research shows that an oral-cavity HPV infection can result from sexual activity with a partner who is infected, specifically through oral sex. In turn, this puts a person at higher risk for oropharyngeal cancer.” (1)

In fact, the CDC notes that “Oral HPV could be passed on during oral sex or open-mouthed or ‘French’ kissing.” (2) Dr. Touyz wrote in a study that “transmission of disease through kissing is accomplished by viral, bacterial, and (rarely) protozoal organisms. Viral infections … are transmitted not only through close sexual contact, but also through exchange of bodily fluids (saliva) from kissing. (Once considered rarely transmissible by saliva, HIV is now acknowledged to be transmissible during intimate kissing.) ...The HPVs-harboured by men and women alike-cause most (but not all) labial, vulval, perineal, penile, and oral papillomata, and dna typing shows that oral and cervical cancers derive from distinct, transmissible HPVs.” (3)

Click to learn more about HPV symptoms.

The CBCD recommends that anyone who suspects that they have an oral HPV infection talk to their doctors about Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was shown to safely and effectively reduce symptoms associated with HPV in two separate post-marketing clinical studies that followed FDA guidelines.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4) The study authors also wrote that “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality and more expensive ingredients.

It should be noted that the CDC says that “there is no FDA-approved test to diagnose HPV in the mouth or throat. Medical and dental organizations do not recommend screening for oral HPV.” (2) Thus, there is no way to know for sure if a person has an oral HPV infection unless the person develops warts in the mouth.

Are there treatments available against the HPV?

“There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (3) In contrast, Novirin and Gene-Eden-VIR were designed to target the latent HPV.

“We recommend that individuals concerned about an infection in the mouth with the latent HPV virus take Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter on here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Firger, J. "HPV Infections Increase Risk for Head and Neck Cancer" Published January 22, 2015
http://europe.newsweek.com/hpv-infections-increase-risk-head-and-neck-cancer-418741?rm=eu

(2) CDC.org - Human papillomavirus (HPV) and Oropharyngeal Cancer - Fact Sheet. Last Updated on November 22, 2013.
cdc.gov/std/hpv/stdfact-hpvandoropharyngealcancer.htm

(3) L.Z.G. Touyz, "Kissing and hpv: honest popular visions, the human papilloma virus, and cancers" Curr Oncol. 2014 Jun; 21(3)

(4) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1 8 http://dx.doi.org/10.4236/pp.2013.46A001

Greg Bennett
CBCD
585-250-9999
email us here